Avai Bio (AVAI) Change in Accured Expenses (2020 - 2023)

Avai Bio has disclosed Change in Accured Expenses across 4 years of filings, most recently posting $440000.0 for Q4 2023.

• Change in Accured Expenses for Q4 2023 came in at $440000.0, up 1034.75% year-over-year; the trailing twelve-month figure through Dec 2023 was $647309.0 (up 196.56% YoY), and the FY2023 annual result was -$2816.0, down 102.33% from the prior year.
• Change in Accured Expenses came in at $440000.0 for Q4 2023 at Avai Bio, up from -$48600.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $440000.0 in Q4 2023 to a low of -$91797.0 in Q4 2021.
• The 4-year median for Change in Accured Expenses is $8208.0 (2020), against an average of $53619.3.
• Peak annual rise in Change in Accured Expenses reached 8073.33% in 2021, while the deepest fall reached 1262.38% in 2021.
• Avai Bio's Change in Accured Expenses stood at -$6738.0 in 2020, then tumbled by 1262.38% to -$91797.0 in 2021, then surged by 142.24% to $38775.0 in 2022, then soared by 1034.75% to $440000.0 in 2023.
• The last three Change in Accured Expenses figures came in at $440000.0 (Q4 2023), -$48600.0 (Q3 2023), and $266000.0 (Q2 2023), per Business Quant data.